Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 …mg, and all treatment-related adverse events were reported as mild, with no severe or serious adverse events occurring. Maze also has another candidate in development, called MZE782, for the treatment… June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Aug 2024 European regulators reject Alzheimer’s drug Leqembi: is it downhill from here? …counterbalance the risk of serious adverse events associated with the medicine.” Table of contents Leqembi safety concerns threaten approval in Europe The pressing safety concern with the drug is a… August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Aug 2025 10 oncology deals in 2025 spotlight where industry leaders are betting big Biotech partnerships play a critical role in driving innovation through the sharing of knowledge, expertise, and resources, and are particularly important in bridging the gap between early-stage research and commercial… August 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2022 Study results reveal bleeding episodes are significantly reduced by hemophilia drug …67 participants exposed to a least one dose of fitusiran, the most common adverse events (in less than six participants) were increased alanine aminotransferase, nasopharyngitis, and upper respiratory tract infection…. July 11, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2021 Gene-Edited T Cell Therapy Players Battle Safety Doubts …Industry experts see these events as a reality check for the nascent field. Off-the-shelf treatments that use genetically engineered T cells to treat diseases suffered a blow to their image… October 22, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Podcast 8 Mar 2024 AI immune system mapping to boost drug discovery …why. “The ability to leverage computational models to find the features that underscore the difference between the responders and non-responders, between toxic events and non-toxic events, between healthy people and… March 8, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2022 Biogen’s New Drug Application for first treatment of rare form of neurological disease accepted by FDA …meaningfully slow the rapid progression of their disease and the impact it has on their lives.” Pain in extremities In the 12-month data, the most common adverse events (AEs) in… July 28, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2018 This Skin Patch Could Slow the Rate of Antibiotic Resistance …than antibiotic resistance, which explains the influx of biotechs into the field. Some big names have switched their attention to the area like Immunocore, which received €33M from the Bill… January 8, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2022 Study data for glioblastoma treatment confirms safety and tolerability profile …tolerated. Dosimetric analysis demonstrates that radiation exposure to key organs is well within acceptable safety limits. The most frequent treatment emergent adverse events (TEAEs) were decreased lymphocyte count, fatigue, headache… September 22, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 8 Feb 2024 Could we see a new dawn for hair loss treatments? There hasn’t been a lot of hair loss treatment progress in the last twenty years. However several biotech companies are hot on the case and are getting tantalizingly close to… February 8, 2024 - 8 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jan 2024 Eight mental health biotech companies trying to make a difference to people’s lives …in depressive symptoms and associated functional impairment. The drug was also well-tolerated with long-term dosing, showing low rates of adverse events and discontinuations due to adverse events. Furthermore, no new… January 25, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 12 Jul 2023 Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden …for the further development of pipeline programs. To create a space for networking, the establishment, which was founded in 1997, has over 300 member companies and hosts around 30 events… July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email